<DOC>
	<DOCNO>NCT00169130</DOCNO>
	<brief_summary>The primary objective study evaluate efficacy ASCT consolidation case bcl-2 overexpression non previously treat patient age 60 year less low-intermediate risk diffuse large B-cell lymphoma respond ACVBP regimen . Our goal obtain 15 % increase event-free survival 2 year .</brief_summary>
	<brief_title>ACVBP Followed ASCT Patients With BCL-2 Positive Diffuse Large B-Cell Lymphoma</brief_title>
	<detailed_description />
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Lymphoma , B-Cell</mesh_term>
	<mesh_term>Lymphoma , Large B-Cell , Diffuse</mesh_term>
	<mesh_term>Cyclophosphamide</mesh_term>
	<mesh_term>Doxorubicin</mesh_term>
	<criteria>Patient diffuse large Bcell lymphoma accord WHO classification ( anti CD20 labeling ) Aged 18 60 year Non previously treat With one one follow adverse characteristic : ECOG performance status 2 , Ann Arbor stage III IV , elevate LDH level Negative HIV , HBV HCV serology ( except vaccination ) With minimum life expectancy 3 month Having previously sign write informed consent Any history treat nontreated indolent lymphoma . Tcell lymphoma . Central nervous system meningeal involvement lymphoma . Any Contraindication drug contain chemotherapy regimen . Poor renal function ( creatinin level &gt; 150µmol/l ) , poor hepatic function ( total bilirubin level &gt; 30mmol/l , transaminase &gt; 2.5 maximum normal level ) unless abnormality relate lymphoma . Serious active disease ( accord investigator ’ decision ) . Poor bone marrow reserve define neutrophil &lt; 1.5G/l platelet &lt; 100G/l , unless relate bone marrow infiltration . Any history cancer last 5 year exception nonmelanoma skin tumor stage 0 ( situ ) cervical carcinoma . Treatment investigational drug within 30 day plan first cycle chemotherapy study . Childbearing woman . Patients previously treat organ transplantation .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>July 2007</verification_date>
	<keyword>lymphoma</keyword>
	<keyword>autologous stem cell transplant</keyword>
	<keyword>chemotherapy</keyword>
	<keyword>BCL2</keyword>
</DOC>